Molecular Characterization of Autoimmune Hepatitis: A Lipidomic Approach

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

About this trial

This is a two-arm, prospective, controlled observational pilot clinical study aimed at characterizing the lipidomic profile and extracellular vesicles (EVs) of patients with autoimmune hepatitis (AIH) compared to patients with non-alcoholic fatty liver disease (NAFLD). A total of 24 adult outpatients will be enrolled at the Hepatology Outpatient Unit of IRCCS "S. de Bellis". Blood samples will be collected by venipuncture to perform lipidomic analyses on red blood cell membranes and serum, and to isolate and characterize EVs. No intervention beyond standard clinical practice will be applied

Eligibility criteria

Qualifiers

Confirmed diagnosis of autoimmune hepatitis (AIH);

Adult age (≥18 years);

Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis"

Disqualifiers

Confirmed diagnosis of non-alcoholic fatty liver disease (NAFLD);

Adult age (≥18 years);

Ability to provide written informed consent; Attending the Hepatology Outpatient Unit of IRCCS "S. de Bellis"

Liver cirrhosis;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

24 Participants
are grouped into 2 trial groups